BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 26, 2019
View Archived Issues
Genetic ablation of CD33 in human stem/progenitor cells enables immunotherapy against leukemia
Read More
When prey becomes predator
Read More
Scorpion venom used to fight S. aureus and M. tuberculosis
Read More
BeiGene updates on clinical results with zanubrutinib
Read More
Colorectal tumors that metastasize do it early
Read More
TNF and tinnitus
Read More
Acer Therapeutics receives complete response letter from FDA for use of Edsivo
Read More
Positive results presented from phase IIb trial of BPX-04 for papulopustular rosacea
Read More
Imbrium plans phase II study of IMB-115 for insomnia associated with alcohol cessation
Read More
FDA clears IND for the PROTAC protein degrader ARV-471
Read More
phiMR-003, a promising new therapeutic phage for MRSA infection
Read More
Positive topline phase I data support continued development of RDN-929
Read More
Statistical significance not achieved for the primary or secondary endpoints of the SOLACE study
Read More
EC grants marketing authorization for Doptelet for severe thrombocytopenia in adults with CLD
Read More
Researchers unveil LRP6 gene to be associated with familial hypercholesterolemia
Read More
Bionomics patents nicotinic alpha7 receptor negative allosteric modulators
Read More
Study gives insights into Parkinson's beyond dopamine
Read More
New lactam derivatives acting as H3 receptor ligands with potential for the treatment of pain
Read More
Researchers identify new compounds for respiratory diseases
Read More
Cadila Healthcare discloses IRAK-4 inhibitors
Read More
AstraZeneca synthesizes new RAS mutant inhibitors
Read More
Vivace Therapeutics presents YAP1/TEAD interaction inhibitors
Read More
FDA issues complete response letter for Ryaltris NDA
Read More
Phase IIb study of SPI-1005 in Meniere's disease meets endpoints
Read More
Promising first data for [212Pb]DOTAMTATE in patients with SSTR-positive neuroendocrine tumors
Read More
FDA allows Translate Bio to begin SAD phase I/II study of MRT-5201 for OTC deficiency
Read More
Faron reports interim data from phase II INFORAAA study of Traumakine
Read More
NantKwest cleared to begin first-in-human study with PD-L1 t-haNK cell therapy
Read More